Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Human Organoids Market: By Product, By Application, By Usability By End Users and Geography
Human Organoids Market: By Product, By Application, By Usability By End Users and Geography
Human Organoids Market size was valued at US$ 2,164.6 million in 2023 and is projected to grow at a 16.2% CAGR from 2024 to 2030. Organoids are stem cell-derived, small, self-organized three-dimensional tissue cultures. Such cultures can be designed to reproduce much of an organ's complexity or express specific features, such as producing only certain types of cells. Organoids develop from stem cells, which can proliferate endlessly and have various cell types as part of their progeny. Organoids range from less than a hair's breadth to five millimeters.
Based on the product type, the global human organoid market is segmented into Liver, Kidney, Pancreas, Colorectal, Heart, and Others. The Liver segment is anticipated to grow at a significant CAGR over the forecast years, owing to greater acceptance of new technologies among academics and academia (combined with expanding industry-academia cooperation for genomic research), technological breakthroughs in 3D scanner bioprinting, and an increase in the number of liver transplants and disorders. Factors such as market technology improvements are driving the expansion of the human organoids industry. Furthermore, increased transplant cases and investments from both the commercial and public sectors are influencing the growth of the human organoids industry
Study Period
2024-2030Base Year
2023CAGR
16.2%Largest Market
Asia PacificFastest Growing Market
North America
Animal models are commonly employed in human-specific scientific research. However, numerous situations show that animal models are not necessarily predictive of human drug response, such as in drug toxicology research. This is because the metabolism of medications and poisons differs significantly between humans and animals, making it practically hard to research drug metabolism in experimental models such as laboratory rodent species. Furthermore, various restrictions have been adopted in recent years that limit the use of animals in scientific operations worldwide.
Similarly, some organizations, including Cruelty-Free International and the Fund for the Replacement of Animals in Medical Experiments, are against using animal-based models in research. It is vital to design alternative testing models to give an environment as close to the human body as possible. Various institutes are active in establishing alternate approaches for medication development and biological research considering this. Because organoids can be used instead of animal models in research, the current emphasis on minimizing animal use in research is projected to help the growth of the human organoids industry.
The largest market share is in North America. This might be linked to the early acceptance of transplantation technology in the area, particularly in the United States, as well as the growing accessibility of human organoid goods due to the presence of well-established distribution channels. Furthermore, due to increased rates of infectious diseases and rising per capita healthcare costs, the Asia Pacific region's market is anticipated to expand at the greatest CAGR over the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 2,164.6 million |
|
Market CAGR |
16.2% |
|
By Product Type |
|
|
By Application |
|
|
By Usability |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global human organoids market size was valued at US$ 2,164.6 million in 2023 and is projected to grow at a CAGR of 16.2% from 2024-2030.
The human organoids market key players are: BioIVT (US) Thermo Fisher Scientific (US) ZenBio (US), Corning (US) Organovo (US) Cyprio (France) Biopredic International (France) CELLINK (Sweden) Emulate (US) Hµrel Corporation (US) InSphero (Switzerland) Kerafast (US) Kirkstall (UK)
The human organoids market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Human Organoids Market Introduction |
| 2.1.Global Human Organoids Market - Taxonomy |
| 2.2.Global Human Organoids Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.Usability |
| 2.2.4.End User |
| 2.2.5.Region |
| 3. Global Human Organoids Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Human Organoids Market Analysis, 2019 - 2030 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Human Organoids Market By Product Type , 2019 - 2030 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Liver |
| 5.1.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Kidney |
| 5.2.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Pancreas |
| 5.3.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Colorectal |
| 5.4.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Heart |
| 5.5.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Human Organoids Market By Application, 2019 - 2030 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Developmental biology |
| 6.1.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Drug toxicity & efficacy testing |
| 6.2.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Disease pathology |
| 6.3.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Personalized medicine |
| 6.4.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Regenerative medicine |
| 6.5.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Other application |
| 6.6.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7. Global Human Organoids Market By Usability , 2019 - 2030 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Ready to use products |
| 7.1.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Customizable products |
| 7.2.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Human Organoids Market By End User, 2019 - 2030 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Pharmaceutical & Biotechnology companies |
| 8.1.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. CROs |
| 8.2.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Academic & Research Institutes |
| 8.3.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Human Organoids Market By Region, 2019 - 2030 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2030 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Human Organoids Market ,2019 - 2030 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Liver |
| 10.1.2.Kidney |
| 10.1.3.Pancreas |
| 10.1.4.Colorectal |
| 10.1.5.Heart |
| 10.1.6.Others |
| 10.2. Application Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Developmental biology |
| 10.2.2.Drug toxicity & efficacy testing |
| 10.2.3.Disease pathology |
| 10.2.4.Personalized medicine |
| 10.2.5.Regenerative medicine |
| 10.2.6.Other application |
| 10.3. Usability Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Ready to use products |
| 10.3.2.Customizable products |
| 10.4. End User Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Pharmaceutical & Biotechnology companies |
| 10.4.2.CROs |
| 10.4.3.Academic & Research Institutes |
| 10.4.4.Others |
| 10.5. Country Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Human Organoids Market ,2019 - 2030 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Liver |
| 11.1.2.Kidney |
| 11.1.3.Pancreas |
| 11.1.4.Colorectal |
| 11.1.5.Heart |
| 11.1.6.Others |
| 11.2. Application Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Developmental biology |
| 11.2.2.Drug toxicity & efficacy testing |
| 11.2.3.Disease pathology |
| 11.2.4.Personalized medicine |
| 11.2.5.Regenerative medicine |
| 11.2.6.Other application |
| 11.3. Usability Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Ready to use products |
| 11.3.2.Customizable products |
| 11.4. End User Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Pharmaceutical & Biotechnology companies |
| 11.4.2.CROs |
| 11.4.3.Academic & Research Institutes |
| 11.4.4.Others |
| 11.5. Country Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Human Organoids Market ,2019 - 2030 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Liver |
| 12.1.2.Kidney |
| 12.1.3.Pancreas |
| 12.1.4.Colorectal |
| 12.1.5.Heart |
| 12.1.6.Others |
| 12.2. Application Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Developmental biology |
| 12.2.2.Drug toxicity & efficacy testing |
| 12.2.3.Disease pathology |
| 12.2.4.Personalized medicine |
| 12.2.5.Regenerative medicine |
| 12.2.6.Other application |
| 12.3. Usability Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Ready to use products |
| 12.3.2.Customizable products |
| 12.4. End User Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Pharmaceutical & Biotechnology companies |
| 12.4.2.CROs |
| 12.4.3.Academic & Research Institutes |
| 12.4.4.Others |
| 12.5. Country Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Human Organoids Market ,2019 - 2030 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Liver |
| 13.1.2.Kidney |
| 13.1.3.Pancreas |
| 13.1.4.Colorectal |
| 13.1.5.Heart |
| 13.1.6.Others |
| 13.2. Application Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Developmental biology |
| 13.2.2.Drug toxicity & efficacy testing |
| 13.2.3.Disease pathology |
| 13.2.4.Personalized medicine |
| 13.2.5.Regenerative medicine |
| 13.2.6.Other application |
| 13.3. Usability Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Ready to use products |
| 13.3.2.Customizable products |
| 13.4. End User Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Pharmaceutical & Biotechnology companies |
| 13.4.2.CROs |
| 13.4.3.Academic & Research Institutes |
| 13.4.4.Others |
| 13.5. Country Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Human Organoids Market ,2019 - 2030 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Liver |
| 14.1.2.Kidney |
| 14.1.3.Pancreas |
| 14.1.4.Colorectal |
| 14.1.5.Heart |
| 14.1.6.Others |
| 14.2. Application Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Developmental biology |
| 14.2.2.Drug toxicity & efficacy testing |
| 14.2.3.Disease pathology |
| 14.2.4.Personalized medicine |
| 14.2.5.Regenerative medicine |
| 14.2.6.Other application |
| 14.3. Usability Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Ready to use products |
| 14.3.2.Customizable products |
| 14.4. End User Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Pharmaceutical & Biotechnology companies |
| 14.4.2.CROs |
| 14.4.3.Academic & Research Institutes |
| 14.4.4.Others |
| 14.5. Country Analysis 2019 - 2030 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.BioIVT (US) |
| 15.2.2.Thermo Fisher Scientific (US) |
| 15.2.3.ZenBio (US), Corning (US) |
| 15.2.4.Organovo (US) |
| 15.2.5.Cyprio (France) |
| 15.2.6.Biopredic International (France) |
| 15.2.7.CELLINK (Sweden) |
| 15.2.8.Emulate (US) |
| 15.2.9.Hµrel Corporation (US) |
| 15.2.10.InSphero (Switzerland) |
| 15.2.11.Kerafast (US) |
| 15.2.12.Kirkstall (UK) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.